Donepezil Memory Preservation Post ECT

Summary

This randomized, placebo-controlled trial will evaluate the use of donepezil compared to placebo to reduce the risk of memory impairment after electroconvulsive therapy (ECT).

Timeline

Start

2015-09-24

Primary completion

2017-01-25

Completion

2017-03-24

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of sufficient enrollment”

Drugs

Indications